Dover Reports First Quarter 2025 Results
1. Dover reported Q1 2025 revenue of $1.9 billion, a 1% decrease. 2. GAAP earnings dropped 60% year-over-year mainly due to prior gains. 3. Adjusted EPS grew by 19% to $2.05, indicating improved operational performance. 4. Management noted strong demand and backlog, especially in biopharma and CO2 systems. 5. 2025 full-year guidance anticipates 2%-4% revenue growth with adjusted EPS of $9.20 to $9.40.